Felipe A. R. Rodrigues, Augusto C. A. Oliveira, Bruno C. Cavalcanti, Marcília P. Costa,
Claudia Pessoa, Alessandra C. Pinheiro, Marcus V. N. de Souza.
Abstract
A series of fifty-four commercial aldehydes have been synthesized and evaluated for their activity against peripheral blood mononuclear
cells (PBMC) and four human cancer cell lines, exhibiting potent citotoxicity (IC50 ranging from 0.36 to 4.75 μg mL-1
). The structureactivity relationship (SAR) analysis indicated that the number, the positions and the type of substituents attached into the aromatic and
heteroaromatic ring are critical for the biological activity. The aldehydes 24, 26, 48 and 49 displayed a potent citotoxicity activity compared
to the reference drug doxorubicin being, therefore, this discovery important for the rational design of new compounds against cancer.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
